| 000 | 01637 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516032745.0 | ||
| 264 | 0 | _c20110607 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1538-3687 | ||
| 024 | 7 |
_a10.1001/archneurol.2011.45 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCree, Bruce A C | |
| 245 | 0 | 0 |
_aEfficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL data. _h[electronic resource] |
| 260 |
_bArchives of neurology _cApr 2011 |
||
| 300 |
_a464-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlack or African American _xethnology |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 |
_aInterferon-beta _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 | _aNatalizumab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aStuart, William H | |
| 700 | 1 | _aTornatore, Carlo S | |
| 700 | 1 | _aJeffery, Douglas R | |
| 700 | 1 | _aPace, Amy L | |
| 700 | 1 | _aCha, Choon H | |
| 773 | 0 |
_tArchives of neurology _gvol. 68 _gno. 4 _gp. 464-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archneurol.2011.45 _zAvailable from publisher's website |
| 999 |
_c20749680 _d20749680 |
||